Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT05091541

Conditions: B-cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL

NCT04913103

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospital Brno Brno, Czechia

University Hospital Hradec Králové Hradec Králové, Czechia

University Hospital Olomouc Olomouc, Czechia

University Hospital Ostrava Ostrava, Czechia

View Trial Details

Not Yet Recruiting

A Phase I/II Study of Diffuse Large B-cell Lymphoma

NCT04856137

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT04595162

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas

NCT04520529

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

NCT02497898

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy

NCT04827862

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Abamson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT06006403

Conditions: Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), +16 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Completed

Shorter Treatment Regimen Implementation Evaluation Study

NCT07747792

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: CIDRZ Lusaka, Lusaka Province, Zambia

View Trial Details

Completed

DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)

NCT06539195

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Hefei, Anhui, China

Research Site Beijing, Beijing Municipality, China

Research Site Guangzhou, Guangdong, China

Research Site Nanning, Guangxi, China

View all 14 locations

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions